Abstract-We conducted a genome-wide association study meta-analysis of mean arterial pressure and pulse pressure among 26 600 East Asian participants (stage 1) followed by replication study of up to 28 783 participants (stage 2). For novel loci, statistical significance was determined by a P<5.0×10 -8 in joint analysis of stage 1 and stage 2 data. For loci reported by the previous mean arterial and pulse pressure genome-wide association study meta-analysis in Europeans, evidence of ). Two additional variants showed suggestive evidence of transethnic replication (consistency in effect direction and P<0.05), including rs319690 at MAP4 (P=0.014) and rs1173771 at NPR3 (P=0.018). For pulse pressure, robust evidence of replication was identified for 2 independent variants, including rs17249754 at ATP2B1 (P=1.2×10 -5 ) and rs11191593 at NT5C2 (P=1.1×10 ). Replicated variants demonstrated consistency in effect sizes between East Asian and European samples, with effect size differences ranging from 0.03 to 0.24 mm Hg for mean arterial pressure and from 0.03 to 0.21 mm Hg for pulse pressure. In conclusion, we present the first evidence of transethnic replication of several mean arterial and pulse pressure loci in an East Asian population. (Hypertension. 2013;62:00-00.) • Online Data Supplement Key Words: blood pressure ■ genetics ■ genome-wide association study ■ hypertension ■ meta-analysis ■ polymorphism, single nucleotide H ypertension affects ≈30% of the world's adult population and has been identified as the leading risk factor for mortality globally.
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November 2013 transethnic replication was determined by consistency in effect direction and a Bonferroni-corrected P<1.4×10 -3 . No novel loci were identified by the current study. Five independent mean arterial pressure variants demonstrated robust evidence for transethnic replication including rs17249754 at ATP2B1 (P=7.5×10 -15 ), rs2681492 at ATP2B1 (P=3.4×10 -7 ), rs11191593 at NT5C2 (1.1×10 -6 ), rs3824755 at CYP17A1 (P=1.2×10 -6 ), and rs13149993 at FGF5 (P=2.4×10 -4 ). Two additional variants showed suggestive evidence of transethnic replication (consistency in effect direction and P<0.05), including rs319690 at MAP4 (P=0.014) and rs1173771 at NPR3 (P=0.018). For pulse pressure, robust evidence of replication was identified for 2 independent variants, including rs17249754 at ATP2B1 (P=1.2×10 -5 ) and rs11191593 at NT5C2 (P=1.1×10 -3 ), with suggestive evidence of replication among an additional 2 variants including rs3824755 at CYP17A1 (P=6.1×10 -3 ) and rs2681492 at ATP2B1 (P=9.0×10 -3 ). Replicated variants demonstrated consistency in effect sizes between East Asian and European samples, with effect size differences ranging from 0.03 to 0.24 mm Hg for mean arterial pressure and from 0.03 to 0.21 mm Hg for pulse pressure. In conclusion, we present the first evidence of transethnic replication of several mean arterial and pulse pressure loci in an East Asian population. (Hypertension. 2013;62:00-00. ) • Online Data Supplement Key Words: blood pressure ■ genetics ■ genome-wide association study ■ hypertension ■ meta-analysis ■ polymorphism, single nucleotide H ypertension affects ≈30% of the world's adult population and has been identified as the leading risk factor for mortality globally. [1] [2] [3] A common complex trait, high blood pressure (BP) is influenced by genomic and environmental factors, as well as their interactions. [4] [5] [6] [7] Recent genome-wide association study (GWAS) meta-analyses have made important strides in advancing hypertension genomic research through the identification of numerous novel loci for systolic BP (SBP) and diastolic BP (DBP). [4] [5] [6] [7] Mean arterial pressure (MAP), defined as the average pressure in the arteries, and pulse pressure (PP), a measure of large artery stiffness, represent 2 additional BP components which also predict cardiovascular disease risk and mortality. [8] [9] [10] [11] Despite their public health relevance and established heritability, [12] [13] [14] only 1 previous GWAS meta-analysis has reported genomic loci influencing these traits. 15 Wain et al 15 described several novel MAP and PP loci which they identified exclusively in populations of European descent. GWAS meta-analyses in distinct ethnic groups could enable the discovery of additional novel loci for MAP and PP and help to determine whether the previously reported variants are relevant to populations of non-European ancestry.
We performed the first ever GWAS meta-analysis of MAP and PP in East Asian participants to (1) identify novel loci influencing MAP and PP and (2) determine whether loci previously identified in populations of European ancestry could be replicated among a distinct ethnic group. Here, we report the results of our 2-stage study that included a meta-analysis of MAP and PP GWAS in 26 600 participants and replication study in up to 28 783 participants.
Methods Stage 1: GWAS Meta-Analysis
The Asian Genetic Epidemiology Network (AGEN)-MAP/PP work group consists of 9 GWAS conducted in East Asian populations. Each AGEN-MAP/PP study collected ≥2 measurements of SBP and DBP in a clinical setting using methods described previously. 6 If participants were taking antihypertension medications, 10 and 5 mm Hg were added to measured SBP and DBP, respectively. Mean MAP and PP were calculated for each participant from SBP and DBP values. Before GWAS, each study imputed the HapMap set of ≈2.4 million single-nucleotide polymorphisms (SNPs). [16] [17] [18] GWAS of MAP and PP in each study was performed using linear regression models to adjust for age, age 2 , sex, body mass index, and enrollment site (for multisite studies). Detailed study-specific information can be found in Table 1 , the Supplementary Note in the online-only Data Supplement, and Table S1 in the online-only Data Supplement.
Inverse-variance weighted fixed-effect meta-analyses of MAP and PP results from the 9 GWAS were performed using METAL. 19 SNPs were excluded if they had minor allele frequency <0.05, HardyWeinberg P<1×10 −6 , call rate <0.95, imputation quality score <0.5, sample size <10 000 or showed evidence of heterogeneity across studies (P for Cochrane Q-test <1×10 −6 ). Genomic control was applied to each study (Table S1 ) and the final meta-analyses (λ GC =1.02 for MAP and λ GC =1.00 for PP; and Figure S1 ).
Stage 2: Replication Studies and Joint Analyses
Novel SNPs were selected for stage 2 replication genotyping by choosing the most significant SNP from loci which achieved a stage 1 P<1.0×10 −5 for MAP or PP. We considered physiological plausibility by also selecting SNPs located within candidate genes 20 if they achieved P<1.0×10 −4 for either MAP or PP or P<1.0×10 −3 for both MAP and PP. For assessment of transethnic replication, previously identified MAP and PP SNPs 15 that achieved nominal significance (P<0.05) in stage 1 study were selected for evaluation in the in silico replication stage.
In silico or de novo replication genotyping and association analyses were conducted in up to 6 additional samples of 28 783 participants (Table 1 , Supplementary Note). Meta-analysis was again used to combine results across the stage 2 studies and conduct joint analysis of stage 1 and stage 2 findings. For novel loci, findings were considered significant if they achieved genome-wide significance (P<5.0×10 −8 ) in the joint analysis. For loci previously identified in European populations, a Bonferroni P<1.35×10 −3 and consistency in effect direction were considered evidence of replication.
Results
In the stage 1 GWAS meta-analysis of 26 600 participants, genome-wide significance was achieved at 12q21.33 (rs17249754) at the widely reported ATP2B1 locus for the MAP phenotype (P=3.65×10 −12 ; Figure 1 and Table 2 ). For PP, novel loci TCL6 at 14q32.13 (rs2145975; P=1.90×10 −8 ) and TTC39C at 18q11.2 (rs11874765; P=3.14×10 −8 ) achieved genome-wide significance in stage 1 study ( Figure 1 and Table S2 ). Six additional novel MAP and PP loci achieved borderline significance (P<1.0×10 −6 ; Figure 1 and Table S2 ). A full list of stage 1 probability values for the associations between each of the 2.4 million SNPs and the MAP and PP phenotypes are publicly available for download at http://www.agenconsortium.org/public_files.php. A total of 35 independent, novel trait-associated SNPs were selected for stage 2 replication study. None achieved genomewide significance in joint analysis of stage 1 and stage 2 findings (Table S2 ). Among 48 SNPs that previously achieved genome-wide significance for MAP or PP traits in European populations, 15 11 independent loci achieved nominal significance in the stage 1 study and were followed up in stage 2 study (Table S3) . Table 2 provides top transethnic replication results. For the MAP phenotype, rs17249754 at ATP2B1 achieved genome-wide significance in the joint analysis of stage 1 and stage 2 studies (P=7.48×10 −15 ). Four additional SNPs showed robust evidence of replication for MAP (consistency of effect direction and significance after adjustment for multiple testing), including rs13149993 at FGF5 (P=2.39×10 −4 ), rs3824755 at CYP17A1 (P=1.21×10 −6 ), rs11191593 at NT5C2 (1.13×10 −6 ), and rs2681492 at ATP2B1 (P=3.39×10 −7 ). Furthermore, 2 SNPs showed suggestive replication (consistency of effect direction and nominal significance [P<0.05]), including rs319690 at MAP4 (P=0.01) and rs1173771 at NPR3 (P=0.02). For the PP phenotype, robust evidence of replication was identified for 2 SNPs including rs11191593 at NT5C2 (P=1.14×10 −3 ) and rs17249754 at ATP2B1 (P=1.21×10 −5 ). Suggestive evidence of replication was identified for 2 additional SNPs including rs3824755 at CYP17A1 (P=6.12×10 −3 ) and rs2681492 at ATP2B1 (P=9.02×10 −3 ). Effect sizes of replicated MAP and PP loci were very similar between the previous GWAS meta-analysis of Europeans 15 and the current GWAS meta-analysis of East Asians (Figure 2 ).
Discussion
The current meta-analysis of 26 600 East Asian participants provided robust transethnic replication evidence for 5 independent SNPs at MAP and PP loci previously identified in populations of European ancestry, 15 including rs13149993 at FGF5, rs3824755 at CYP17A1, rs11191593 at NT5C2, rs2681492 at ATP2B1, and rs17249754 at ATP2B1. In addition, 2 SNPs, rs319690 at MAP4 and rs1173771 at NPR3, showed suggestive evidence of transethnic replication. Further examination of these 7 variants demonstrated remarkable consistency in per allele effect sizes across populations of East Asian and European ancestry.
Seven SNPs from MAP and PP loci identified in samples of European ancestry showed evidence of transethnic replication in the current study of East Asians. Marker rs17249754 at the ATP2B1 locus (12q21.33) achieved genome-wide significance for MAP and was robustly associated with PP. Furthermore, rs2681492, a moderately correlated intronic ATP2B1 SNP (r 2 =0.78), also showed evidence of transethnic replication for the MAP and PP phenotypes. ATP2B1 is a widely reported BP-related gene, with marker rs17249754 also identified for GWAS meta-analysis. Loci highlighted in blue indicate the 2-Mb regions of SNPs that achieved genome-wide significance in the GWAS metaanalysis of Europeans (unless achieving P<1E-6 in the current study). 15 Loci that achieved genomewide significance in Europeans 15 or East Asians are labeled (blue if originally identified in Europeans; black if originally identified in the current study).
by guest on April 9, 2017 http://hyper.ahajournals.org/ Downloaded from the SBP and DBP phenotypes in East Asians. [4] [5] [6] [7] 15 ATP2B1 is thought to exert its influence on BP regulation through alteration of calcium handling and vasoconstriction in vascular smooth muscle cells. 21 At 3p21.31, the current study provided the first evidence of association for marker rs319690 with a BP-related phenotype among individuals with East Asian ancestry. Marker rs319690 represents an intronic variant of the MAP4 gene, implicated in heart failure through its interference with β-adrenergic receptor recycling. 22 At the FGF5 locus (4q21.21), marker rs13149993 was associated with both MAP and PP phenotypes in the current study. The FGF5 rs13149993 variant (or a proxy [r 2 >0.8]) has been reported previously for its associations with not only MAP but also other BP-related phenotypes. 5, 7, 15 Furthermore, a variant modestly correlated with rs13149993 at FGF5, rs16998073 (r 2 =0.49), was previously related to SBP and DBP in East Asians. 6, 23 FGF5, a fibroblast growth factor gene, is expressed in cardiac myocytes and has been shown to promote angiogenesis in the heart. 24 Near NPR3 (at 5p13.3), rs1173771 was associated with MAP in the current study. Previously reported for its association with MAP in whites and other BP phenotypes in whites and East Asians, 6, 7, 15 NPR3 encodes the natriuretic peptide receptor C, a peptide known to regulate BP and fluid homeostasis by modifying glomerular filtration rate and sodium urinary excretion. 25 Finally, moderately correlated SNPs rs3824755 and rs11191593 (r 2 =0.67) at 10q24.32 and 10q24.33, respectively, were associated with MAP and PP in the current study. Marker rs3824755 is an intronic variant of CYP17A1, the gene responsible for the monogenic BP disorder congenital adrenal hyperplasia, 26 whereas rs11191593 is an intronic variant of NT5C2, a gene involved in DNA synthesis with no known functional role in BP regulation. 27 Marker rs3824755 (or a proxy) was previously reported to associate with not only MAP and PP 15 but also SBP in the article by Levy et al, 4 whereas rs11191593 (or a proxy) has been reported previously for numerous BP phenotypes, including SBP and DBP in East Asians. [5] [6] [7] 15 The current GWAS meta-analysis represents the largest genetic association study of MAP and PP conducted in participants of East Asian ancestry to date. Additional study strengths include the adherence of all studies to a standard analytic protocol and stringent genotyping and imputation 6 §Significant after Bonferroni correction for 37 statistical tests. ║Although there is evidence of significance for PP, this variant was only identified for MAP in the study by Wain et al. 15 Therefore, this does not represent evidence of transethnic replication of rs1004467, a proxy for rs3824755 in East Asian samples (r 2 =0.95), achieved genome-wide significance for MAP in the study by Wain et al. 15 ¶rs11191548, a proxy for rs1191593 in East Asian samples (r 2 =1.00), achieved genome-wide significance for PP in the study by Wain et al. quality control procedures at the study and meta-analysis levels. Despite these strengths, the current study failed to identify any novel loci related to MAP and PP traits. Although currently this was the largest study conducted in East Asians, the stage 1 sample was only one-third the size of that of the prior GWAS meta-analysis of MAP and PP conducted in populations of European ancestry. 15 Thus, we still may have lacked the statistical power needed to identify novel variants for MAP and PP. Furthermore, we did not replicate 24 of the 31 loci previously identified in Europeans. Lack of replication could be related to differences in linkage disequilibrium (LD) patterns between Europeans and East Asians. To address this concern, we examined interpopulation LD variation at these loci. 28 Our results showed that LD structure was generally similar between populations at all but 5 regions (see Figure S2 ). However, examination of variants in LD with the lead SNP in Europeans did not reveal any further significant associations in East Asians, suggesting that differences in LD may not have been a major factor limiting replication in the current study (data not shown). Lack of replication could also be attributable to limited statistical power. To assess this issue, we compared effect sizes and minor allele frequencies of independent SNPs which achieved genome-wide significance in Europeans between the 2 studies (Table S4) . Despite differences in the minor allele frequency of many of the variants, very strong correlations in effect sizes between populations were observed (Table S4) . Furthermore, power calculations demonstrated that we lacked the statistical power to detect associations for the 24 unreplicated loci (Table S5 ). These data suggest the existence of additional promising MAP and PP loci in East Asian populations that may be identified by future, larger GWAS meta-analyses.
Perspectives
The current study of 26 600 East Asian participants from 9 GWAS provides the first evidence of transethnic replication of 7 MAP and PP loci previously identified in populations of European ancestry. In addition, we demonstrate remarkable consistency in allelic effect sizes between populations with vast differences in not only genomic ancestry but also environmental and cultural factors. Our findings add to the accumulating evidence that many genomic associations are reproducible in populations with distinct LD structure, suggesting common genomic mechanisms underlying the development of hypertension and cardiovascular disease across populations.
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Disclosures
None. What Is New?
• The current genome-wide association study meta-analysis of 26 600
East Asians provides the first evidence of transethnic replication of 7 mean arterial pressure and pulse pressure loci previously identified in populations of European ancestry.
• Per allele effect sizes of replicated variants were consistent between Europeans and East Asians.
What Is Relevant?
• The physiological effects of many common polymorphisms may be generalizable across populations.
Summary
The current meta-analysis of 26 600 East Asian participants from 9 genome-wide association study provided evidence of transethnic replication for 7 mean arterial pressure and pulse pressure variants previously identified in populations of European ancestry. 15 These variants demonstrated remarkable consistency in per allele effect sizes across populations of East Asian and European ancestry. We add to the accumulating evidence that many genomic associations are reproducible in populations with distinct linkage disequilibrium structure, suggesting common genomic mechanisms underlying the development of hypertension and cardiovascular disease across populations. This section provides a more detailed description of the study populations and methods of 4 GWAS included in the stage-1 GWAS meta-analysis. All participants provided written informed 5 consent. All studies were approved by local Research Ethics Committees and/or Institutional 6
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GENOME-WIDE ASSOCIATION STUDY META-ANALYSIS REVEALS TRANS-ETHNIC REPLICATION OF MEAN ARTERIAL AND PULSE PRESSURE LOCI
Review boards and followed procedures that were in accordance with institutional guidelines. 7 8
The CAGE Network 9
The Cardio-metabolic Genome Epidemiology (CAGE) Network is an ongoing collaborative 10 effort to investigate genetic and environmental factors, and their interactions affecting 11 cardiometabolic traits/disorders among Asian populations, including the Japanese 1 . CAGE 12 participants were recruited in a population-based or hospital-based setting, depending on the 13 design of member studies. From this network sample, a total of 1,547 Japanese samples were 14 used for GWAS of mean arterial pressure (MAP) and pulse pressure (PP). These subjects were 15 enrolled at four separate sites in Japan including the Tokyo, Nagoya, Osaka participants (n=60,401). After the participants sat quietly for more than five minutes, systolic and 5 diastolic BP were taken using an aneroid sphygmomanometer according to a standard protocol. 6 An average of at least two BP measurements was used for this analysis. 7
All SMHS and SWHS samples were processed with a uniform quality control protocol. The 8 samples were genotyped for several projects, and those projects have been described elsewhere 16-9 20 . For this analysis, we used the subset of 3,754 participants from a total of 8,847 participants 10 with GWAS data with at least 2 measures of BP. Detailed information on genotyping, quality 11 control, imputation, and genotype-phenotype analyses are presented in Supplementary The Japanese Millenium Genome Project (JMPG) comprises 6 independent study cohorts for 8 studies of cardiovascular diseases and related risk factors. The Ohasama, Shigaraki, Takashima,  9 and Nomura Ehime studies are general population based genetic epidemiological studies of 10 subjects recruited via a medical check-up process for community-residents. The Ohasama study 11 is a population-based longitudinal epidemiological study focusing on the clinical implications of 12 home BP measurement. The Shigaraki and Takashima studies of Shiga University of Medical 13 Science are general population-based longitudinal studies and subjects were recruited through a 14 community-based annual medical check-up process. 
